Femastin

SRT cream is indicated for estrogen deficiency. During menopause, the amount of estrogen a woman's body produces gradually declines. A shortage of estrogen causes the vaginal wall to become thin and dry, which leads to painful sexual intercourse. SRT cream is used to relieve painful sexual intercourse. It is used in postmenopausal women who have had at least 12 months since their last natural period. If the ovaries are removed surgically (ovariectomy) before menopause, the decrease in estrogen production occurs very abruptly.

Local irritation or itching of the vagina, swelling and increased tenderness of the breasts, increased vaginal discharge, nausea, and fluid retention in the tissues (usually noticed as swollen ankles or feet) may occur. In most patients these side effects disappear after the first few weeks of treatment. Tell your doctor if vaginal bleeding occurs, or if any side effect becomes troublesome or persists. Other side effects that may occur with HRT include benign and malignant hormone-dependent tumours such as endometrial cancer; heart attack and stroke; gall bladder disease; skin problems such as rashes, discoloration or red patches on the skin, various skin diseases with blisters and nodules, or bleeding into the skin; and venous thromboembolism, deep vein thrombosis of the leg or pelvis, and pulmonary embolism (see Before you use SRT Cream). Using HRT for several years slightly increases the risk of breast cancer.